Wells Fargo & Company Verrica Pharmaceuticals Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 5,832 shares of VRCA stock, worth $46,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,832

Previous 6,062 3.79%

Holding current value

$46,364

Previous $44,000 4.55%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.95 - $7.95 $1,828 - $1,828	-230 Reduced 3.79%	5,832 $46,000
Q2 2024 Aug 13, 2024	SELL	$5.89 - $9.56 $9,871 - $16,022	-1,676 Reduced 21.66%	6,062 $44,000
Q1 2024 May 10, 2024	SELL	$4.74 - $6.81 $10,262 - $14,743	-2,165 Reduced 21.86%	7,738 $45,000
Q4 2023 Feb 09, 2024	BUY	$2.93 - $7.32 $12,393 - $30,963	4,230 Added 74.56%	9,903 $72,000
Q3 2023 Nov 13, 2023	SELL	$3.75 - $7.46 $16,965 - $33,749	-4,524 Reduced 44.37%	5,673 $22,000
Q2 2023 Aug 15, 2023	BUY	$5.32 - $6.79 $45,587 - $58,183	8,569 Added 526.35%	10,197 $58,000
Q1 2023 May 12, 2023	BUY	$2.88 - $8.51 $5 - $17	2 Added 0.12%	1,628 $10,000
Q4 2022 Feb 13, 2023	BUY	$2.09 - $3.39 $6 - $10	3 Added 0.18%	1,626 $4,000
Q3 2022 Nov 14, 2022	BUY	$2.17 - $4.3 $2,269 - $4,497	1,046 Added 181.28%	1,623 $4,000
Q2 2022 Aug 12, 2022	SELL	$1.81 - $8.93 $9,788 - $48,293	-5,408 Reduced 90.36%	577 $1,000
Q1 2022 May 16, 2022	SELL	$7.59 - $9.49 $33,449 - $41,822	-4,407 Reduced 42.41%	5,985 $48,000
Q4 2021 Feb 14, 2022	SELL	$9.1 - $13.36 $94,103 - $138,155	-10,341 Reduced 49.88%	10,392 $96,000
Q3 2021 Nov 15, 2021	BUY	$9.55 - $13.96 $192,976 - $282,089	20,207 Added 3841.63%	20,733 $259,000
Q2 2021 Aug 16, 2021	SELL	$9.77 - $15.33 $36,862 - $57,840	-3,773 Reduced 87.76%	526 $6,000
Q1 2021 May 13, 2021	SELL	$10.51 - $17.46 $93,812 - $155,847	-8,926 Reduced 67.49%	4,299 $65,000
Q4 2020 Feb 09, 2021	BUY	$7.41 - $12.63 $17,361 - $29,592	2,343 Added 21.53%	13,225 $152,000
Q3 2020 Nov 05, 2020	SELL	$6.16 - $10.3 $13,133 - $21,959	-2,132 Reduced 16.38%	10,882 $85,000
Q2 2020 Aug 13, 2020	BUY	$9.02 - $15.12 $5,006 - $8,391	555 Added 4.45%	13,014 $143,000
Q1 2020 May 14, 2020	BUY	$7.14 - $16.86 $88,957 - $210,058	12,459 New	12,459 $136,000

Others Institutions Holding VRCA

# of Institutions

Shares Held

14.2M

Call Options Held

9.9K

Put Options Held

6.5K

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Verrica Pharmaceuticals Inc. Transaction History